These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19281075)

  • 1. Safety, tolerability and risk benefit analysis of tiotropium in COPD.
    Oba Y; Zaza T; Thameem DM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):575-84. PubMed ID: 19281075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.
    Saberi F; O'Donnell DE
    Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR; ZuWallack RL
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
    Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
    Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe.
    Fležar M; Jahnz-Różyk K; Enache G; Martynenko T; Kristufek P; Škrinjarić-Cincar S; Kadlecová P; Martinovic G
    Int J Chron Obstruct Pulmon Dis; 2013; 8():483-92. PubMed ID: 24159258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].
    Ohmura T; Nishikawa H
    Nihon Yakurigaku Zasshi; 2005 May; 125(5):307-13. PubMed ID: 15997169
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
    Niewoehner DE; Rice K; Cote C; Paulson D; Cooper JA; Korducki L; Cassino C; Kesten S
    Ann Intern Med; 2005 Sep; 143(5):317-26. PubMed ID: 16144890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2012 Jan; 72(2):273-300. PubMed ID: 22217233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
    Hodder R; Kesten S; Menjoge S; Viel K
    Int J Chron Obstruct Pulmon Dis; 2007; 2(2):157-67. PubMed ID: 18044688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 13. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR
    Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
    McIvor RA
    Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792
    [No Abstract]   [Full Text] [Related]  

  • 15. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.
    Panning CA; DeBisschop M
    Pharmacotherapy; 2003 Feb; 23(2):183-9. PubMed ID: 12587807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium bromide.
    Gross NJ
    Chest; 2004 Dec; 126(6):1946-53. PubMed ID: 15596697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.
    Hansel TT; Barnes PJ
    Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.
    Abrahams R; Moroni-Zentgraf P; Ramsdell J; Schmidt H; Joseph E; Karpel J
    Respir Med; 2013 Jun; 107(6):854-62. PubMed ID: 23490224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J; Zhou Z; Tang Y; Zhong N
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.